↗6 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$737KSold on the market
1Companies
Oct 21, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202617:51 | Oct 19, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $38.47 | −5,000 | 25,000 | -17% | −$192K | ||
| Oct 21, 202617:51 | Oct 19, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K | ||
| Sep 21, 202617:22 | Sep 17, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $50.35 | −5,000 | 25,000 | -17% | −$252K | ||
| Sep 21, 202617:22 | Sep 17, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K | ||
| Aug 19, 202616:16 | Aug 17, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $58.59 | −5,000 | 25,000 | -17% | −$293K | ||
| Aug 19, 202616:16 | Aug 17, 2026 | ELVNEnliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K |